secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marpai, Inc. (MRAI)
CIK:        0001844392
Form:       8-K
Filed at:   2023-06-30T23:59:59+00:00
Accession:  0000950170-23-030886
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marpai confirms Q2 2023 revenue guidance of $9.5M-$9.8M; expects EBITDA improvement
--------------------------------------------------------------------------------

- Preliminary Q2 2023 revenue between $9.5M and $9.8M.
- Expects sequential improvement in EBITDA and net income vs Q1 2023.
- Progress on Maestro Health integration and cost-cutting cited for improved profitability.
- Revenue roughly flat sequentially as previously anticipated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023030886/0000950170-23-030886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023030886/mrai-20230629.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-030886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer